pyrazolanthrone has been researched along with Experimental Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, JM; Jang, WY; Jeong, YI; Jung, S; Li, CH; Lim, SH | 1 |
| Ji, L; Lu, B; Shi, L; Zhang, G; Zheng, Z | 1 |
2 other study(ies) available for pyrazolanthrone and Experimental Neoplasms
| Article | Year |
|---|---|
Enhancing Radiotherapeutic Effect With Nanoparticle-Mediated Radiosensitizer Delivery Guided By Focused Gamma Rays In Lewis Lung Carcinoma-Bearing Mouse Brain Tumor Models.
Topics: Animals; Anthracenes; Apoptosis; Biological Availability; Brain Neoplasms; Carcinoma, Lewis Lung; DNA Damage; Drug Delivery Systems; Female; Gamma Rays; Humans; Hydrogen-Ion Concentration; JNK Mitogen-Activated Protein Kinases; Methyltransferases; Mice, Inbred C57BL; Nanoparticles; Neoplasms, Experimental; Polyethylene Glycols; Radiation-Sensitizing Agents; Tumor Microenvironment | 2019 |
Andrographolide reduced VEGFA expression in hepatoma cancer cells by inactivating HIF-1α: The involvement of JNK and MTA1/HDCA.
Topics: Animals; Anthracenes; Carcinoma, Hepatocellular; Diterpenes; Dose-Response Relationship, Drug; Down-Regulation; Histone Deacetylase 1; Histone Deacetylases; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; JNK Mitogen-Activated Protein Kinases; Liver Neoplasms; Male; Mice; Mice, Nude; Neoplasms, Experimental; Repressor Proteins; Structure-Activity Relationship; Trans-Activators; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2017 |